Identification and immunoprofiling of key prognostic genes in the tumor microenvironment of hepatocellular carcinoma

References

• Maluccio M, Covey A .。Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin. 2012 2012-11-01;62(6):394–399. PMID: 23070690.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Han QJ, Zhang J. Hepatocellular carcinoma: mechanisms of progression and immunotherapy. World J Gastroenterol. 2019 2019-07-07;25(25):3151–3167. PMID: 31333308.
   PubMed Web of Science ®Google Scholar
• Li L, Lei Q, Zhang S, et al. Screening and identification of key biomarkers in hepatocellular carcinoma: evidence from bioinformatic analysis. Oncol Rep. 2017 2017-11-01;38(5):2607–2618. PMID: 28901457.
   PubMed Web of Science ®Google Scholar
• Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013 2013-11-01;19(11):1423–1437. PMID: 24202395.
   PubMed Web of Science ®Google Scholar
• Chen F, Zhuang X, Lin L, et al. New horizons in tumor microenvironment biology: challenges and opportunities. Bmc Med. 2015 2015-03-05;13:45. PMID: 25857315. 10.1186/s12916-015-0278-7. 13 1
   Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. CELL. 2011 2011-03-04;144(5):646–674. PMID: 21376230.
   PubMed Web of Science ®Google Scholar
• Jia D, Li S, Li D, et al. TCGA database for genes of prognostic value in glioblastoma microenvironment. Aging (Albany NY). 2018 2018-04-16;10(4):592–605. PMID: 29676997.
   PubMedGoogle Scholar
• Yoshihara K, Shahmoradgoli M, Martinez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013 2013-01-20;4:2612. PMID: 24113773. 1
   PubMed Web of Science ®Google Scholar
• Alonso MH, Ausso S, Lopez-Doriga A, et al. Comprehensive analysis of copy number aberrations in microsatellite stable colon cancer in view of stromal component. Br J Cancer. 2017 2017-07-25;117(3):421–431. PMID: 28683472.
   PubMed Web of Science ®Google Scholar
• Senbabaoglu Y, Gejman RS, Winer AG, et al. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biol. 2016 2016-11-17;17(1):231. PMID: 27855702.
   PubMed Web of Science ®Google Scholar
• Priedigkeit N, Watters RJ, Lucas PC, et al. Exome-capture RNA sequencing of decade-old breast cancers and matched decalcified bone metastases. JCI Insight. 2017 2017-09-07;2(17). PMID: 28878133. 10.1172/jci.insight.95703.
   PubMed Web of Science ®Google Scholar
• Shah N, Wang P, Wongvipat J, et al. Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer. ELIFE. 2017 2017-09-11;6. PMID: 28891793. 10.7554/eLife.27861.
   Web of Science ®Google Scholar
• Meng Z, Ren D, Zhang K, et al. Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in pancreatic adenocarcinoma. Aging (Albany NY). 2020 2020-03-17;12(6):5048–5070. PMID: 32181755.
   PubMedGoogle Scholar
• Ye L, Zhang T, Kang Z, et al.et al. Tumor-infiltrating immune cells act as a marker for prognosis in colorectal cancer. Front Immunol. 2019 2019-01-20;10:2368. PMID: 31681276.
   PubMed Web of Science ®Google Scholar
• Workel HH, Komdeur FL, Wouters MC, et al. CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma. Eur J Cancer. 2016 2016-06-01;60:1–11. PMID: 27038842.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang Y, Xu L, et al. CD4 + T cells promote renal cell carcinoma proliferation via modulating YBX1. Exp Cell Res. 2018 2018-02-01;363(1):95–101. PMID: 29289594.
   PubMed Web of Science ®Google Scholar
• Bense RD, Sotiriou C, Piccart-Gebhart MJ, et al. Relevance of tumor-infiltrating immune cell composition and functionality for disease outcome in breast cancer. J Natl Cancer Inst. 2017 2017-01-01;109(1). PMID: 27737921. djw192
   PubMedGoogle Scholar
• Youngblood B, Hale JS, Kissick HT, et al. Effector CD8 T cells dedifferentiate into long-lived memory cells. NATURE. 2017 2017-12-21;552(7685):404–409. PMID: 29236683.
   PubMed Web of Science ®Google Scholar
• Garnelo M, Tan A, Her Z, et al. Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma. GUT. 2017 2017-02-01;66(2):342–351. PMID: 26669617.
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. CELL. 2010 2010-03-19;140(6):883–899. PMID: 20303878.
   PubMed Web of Science ®Google Scholar
• Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015 2015-05-01;12(5):453–457. PMID: 25822800.
   PubMed Web of Science ®Google Scholar
• Zeng D, Zhou R, Yu Y, et al. Gene expression profiles for a prognostic immunoscore in gastric cancer. Br J Surg. 2018 2018-09-01;105(10):1338–1348. PMID: 29691839.
   PubMed Web of Science ®Google Scholar
• Ali HR, Chlon L, Pharoah PD, et al. Patterns of immune infiltration in breast cancer and their clinical implications: a gene-expression-based retrospective study. Plos Med. 2016 2016-12-01;13(12):e1002194. PMID: 27959923.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Wang K, Zhou H, et al. Profiles of immune infiltration in colorectal cancer and their clinical significant: a gene expression-based study. Cancer Med. 2018 2018-09-01;7(9):4496–4508. PMID: 30117315.
   PubMed Web of Science ®Google Scholar
• Hong W, Yuan H, Gu Y, et al. Immune-related prognosis biomarkers associated with osteosarcoma microenvironment. Cancer Cell Int. 2020 2020-01-20;20:83. PMID: 32190007. 1
   PubMed Web of Science ®Google Scholar
• Qu Y, Cheng B, Shao N, et al. Prognostic value of immune-related genes in the tumor microenvironment of lung adenocarcinoma and lung squamous cell carcinoma. Aging (Albany NY). 2020 2020-03-25;12(6):4757–4777. PMID: 32209727
   PubMedGoogle Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015 2015-04-20;43(7):e47. PMID: 25605792.
   PubMed Web of Science ®Google Scholar
• Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. BIOINFORMATICS. 2016 2016-09-15;32(18):2847–2849. PMID: 27207943.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003 2003-11-01;13(11):2498–2504. PMID: 14597658.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005 2005-10-25;102(43):15545–15550. PMID: 16199517.
   PubMed Web of Science ®Google Scholar
• Labeur TA, Achterbergh R, Takkenberg B, et al. Sorafenib for patients with hepatocellular carcinoma and child-pugh B liver cirrhosis: lessons learned from a terminated study. ONCOLOGIST. 2020 2020-09-01;25(9):e1274–9. PMID: 31645371.
   PubMed Web of Science ®Google Scholar
• Yang JD, Nakamura I, Roberts LR. The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin Cancer Biol. 2011 2011-02-01;21(1):35–43. PMID: 20946957.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Chen D, Li Z, et al. Bioinformatics analysis to screen the key prognostic genes in tumor microenvironment of bladder cancer. Biomed Res Int. 2020-01-20;2020:6034670. PMID: 32149116. 10.1155/2020/6034670.
   PubMedGoogle Scholar
• Galon J, Angell HK, Bedognetti D, et al. The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. IMMUNITY. 2013 2013-07-25;39(1):11–26. PMID: 23890060.
   PubMed Web of Science ®Google Scholar
• Deng Z, Wang J, Xu B, et al. Mining TCGA database for tumor microenvironment-related genes of prognostic value in hepatocellular carcinoma. Biomed Res Int. 2019-01-20;2019:2408348. PMID: 31828095. 10.1155/2019/2408348.
   PubMedGoogle Scholar
• Rotte A. Combination of CTLA-4 and PD-1 blockers for treatment of cancer. J Exp Clin Cancer Res. 2019 2019 Jun 13;38(1):255. PMID: 31196207.
   PubMed Web of Science ®Google Scholar
• Caronni N, Savino B, Recordati C, et al. Cancer and chemokines. Methods Mol Biol. 2016 2016-01-20;1393:87–96. PMID: 27033218.
   PubMedGoogle Scholar
• Alain P, Vicari A, Christophe C. Chemokines in cancer. CYTOKINE GROWTH F R. 2002.
   Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. NATURE. 2002;420(6917):860–867.
   PubMed Web of Science ®Google Scholar
• Richmond A, Thomas HG. Purification of melanoma growth stimulatory activity. J Cell Physiol. 1986 1986-12-01;129(3):375–384. PMID: 3465735.
   PubMed Web of Science ®Google Scholar
• Yang L, Chang Y, Cao P. CCR7 preservation via histone deacetylase inhibition promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells. Exp Cell Res. 2018 2018-10-01;371(1):231–237. PMID: 30107147.
   PubMed Web of Science ®Google Scholar
• Li W, Wang H, Ma Z, et al. Multi-omics analysis of microenvironment characteristics and immune escape mechanisms of hepatocellular carcinoma. Front Oncol. 2019 2019-01-20;9:1019. PMID: 31681571
   PubMed Web of Science ®Google Scholar
• Nagarsheth N, Wicha MS, Zou W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol 2017. 17 9 559–572.
   PubMed Web of Science ®Google Scholar
• Karin N. Chemokines and cancer: new immune checkpoints for cancer therapy. Curr Opin Immunol. 2018;51:140.
   PubMed Web of Science ®Google Scholar
• Mollica PV, Massara M, Capucetti A, et al. Chemokines and chemokine receptors: new targets for cancer immunotherapy. Front Immunol. 2019 2019-01-20;10:379. PMID: 30894861.
   PubMed Web of Science ®Google Scholar
• Babar M, Ryan AW, Anderson LA, et al. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett’s esophagus and esophageal adenocarcinoma. Am J Gastroenterol. 2012 2012-09-01;107(9):1331–1341. PMID: 22664470.
   PubMed Web of Science ®Google Scholar
• Tian Z, Wang Z, Chen Y, et al. Bioinformatics analysis of prognostic tumor microenvironment-related genes in the tumor microenvironment of hepatocellular carcinoma. Med Sci Monit. 2020 2020-03-31;26:e922159. PMID: 32231177.
   PubMed Web of Science ®Google Scholar
• Zhao J, Ou B, Han D, et al. Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3beta/beta-catenin pathways. Mol Cancer. 2017 2017-03-29;16(1):70. PMID: 28356111.
   PubMedGoogle Scholar
• Chen C, Xu ZQ, Zong YP, et al.et al. CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-kappaB pathway in colorectal cancer. Cell Death Dis. 2019 2019-02-21;10(3):178. PMID: 30792394.
   PubMedGoogle Scholar
• Haider C, Hnat J, Wagner R, et al. Transforming growth factor-beta and axl induce CXCL5 and neutrophil recruitment in hepatocellular carcinoma. HEPATOLOGY. 2019 2019-01-01;69(1):222–236. PMID: 30014484.
   PubMed Web of Science ®Google Scholar
• Zhou SL, Zhou ZJ, Hu ZQ, et al. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3beta/Snail signaling. Cancer Lett. 2015 2015-03-28;358(2):124–135. PMID: 25462858.
   PubMed Web of Science ®Google Scholar
• Zhang W, Wang H, Sun M, et al. CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target. Cancer Commun (Lond). 2020 2020-03-01;40(2–3):69–80. PMID: 32237072.
   PubMed Web of Science ®Google Scholar
• Zhu J, Zhou Y, Wang L, et al. CXCL5/CXCL8 is a promising potential prognostic and tumor microenvironment-related cluster in hepatocellular carcinoma. J Gastrointest Oncol. 2020 2020-12-01;11(6):1364–1380. PMID: 33457007.
   PubMed Web of Science ®Google Scholar
• Tang W, Lv B, Yang B, et al. TREM2 acts as a tumor suppressor in hepatocellular carcinoma by targeting the PI3K/Akt/beta-catenin pathway. ONCOGENESIS. 2019 2019-01-25;25(9):9. PMID: 30683932.
   Google Scholar
• Ye L, Li Y, Tang H, et al. CD8+CXCR5+T cells infiltrating hepatocellular carcinomas are activated and predictive of a better prognosis. Aging (Albany NY). 2019;11(20). 20
   Google Scholar
• Jobin PG, Solis N, Machado Y, et al. Moonlighting matrix metalloproteinase subsRtrates: enhancement of proinflammatory functions of extracellular tyrosyl-tRNA synthetase upon cleavage. J Biol Chem. 2020 2020-02-21;295(8):2186–2202. PMID: 31771979.
   PubMed Web of Science ®Google Scholar
• Zhou SL, Dai Z, Zhou ZJ, et al. CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils. CARCINOGENESIS. 2014 2014-03-01;35(3):597–605. PMID: 24293410.
   PubMed Web of Science ®Google Scholar
• Kowalczuk O, Burzykowski T, Niklinska WE, et al. CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes. Tumour Biol. 2014 2014-05-01;35(5):4619–4628. PMID: 24500664.
   PubMedGoogle Scholar
• Begley LA, Kasina S, Mehra R, et al. CXCL5 promotes prostate cancer progression. NEOPLASIA. 2008 2008-03-01;10(3):244–254. PMID: 18320069.
   PubMed Web of Science ®Google Scholar
• Li A, King J, Moro A, et al. Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer. Am J Pathol. 2011 2011-03-01;178(3):1340–1349. PMID: 21356384.
   PubMed Web of Science ®Google Scholar
• Wong YF, Cheung TH, Lo KW, et al. Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling. ONCOGENE. 2007 2007-03-22;26(13):1971–1982. PMID: 17043662.
   PubMed Web of Science ®Google Scholar
• Miyazaki H, Patel V, Wang H, et al. Down-regulation of CXCL5 inhibits squamous carcinogenesis. Cancer Res. 2006 2006-04-15;66(8):4279–4284. PMID: 16618752.
   PubMed Web of Science ®Google Scholar
• Gao Y, Guan Z, Chen J, et al. CXCL5/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K/AKT-induced upregulation of MMP2/MMP9. Int J Oncol. 2015 2015-08-01;47(2):690–700. PMID: 26058729.
   PubMed Web of Science ®Google Scholar
• Speetjens FM, Kuppen PJK, Sandel MH, et al. Disrupted expression of CXCL5 in colorectal cancer is associated with rapid tumor formation in rats and poor prognosis in patients. Clin Cancer Res. 2008;14(8):2276–2284.
   PubMed Web of Science ®Google Scholar
• Lopez-Lago MA, Posner S, Thodima VJ, et al. Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression. ONCOGENE. 2013 2013-04-04;32(14):1752–1760. PMID: 22665059.
   PubMed Web of Science ®Google Scholar
• Benoy IH, Salgado R, Van Dam P, et al. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin Cancer Res. 2004 2004-11-01;10(21):7157–7162. PMID: 15534087.
   PubMed Web of Science ®Google Scholar
• Lin GW, Xu C, Chen K, et al. Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations. Lancet Oncol. 2020 2020-02-01;21(2):306–316. PMID: 31879220.
   PubMed Web of Science ®Google Scholar
• Molgora M, Esaulova E, Vermi W, et al. TREM2 modulation remodels the tumor myeloid landscape enhancing anti-PD-1 immunotherapy. CELL. 2020 2020-08-20;182(4):886–900. PMID: 32783918.
   PubMed Web of Science ®Google Scholar